Financials data is unavailable for this security.
View more
Year on year Medikit Co Ltd had relatively flat revenues (21.61bn to 21.85bn), though the company grew net income 7.15% from 2.86bn to 3.07bn. A reduction in the cost of goods sold as a percentage of sales from 61.50% to 59.94% was a component in the net income growth despite flat revenues.
Gross margin | 38.75% |
---|---|
Net profit margin | 13.58% |
Operating margin | 20.70% |
Return on assets | 5.69% |
---|---|
Return on equity | 6.56% |
Return on investment | 6.40% |
More ▼
Cash flow in JPYView more
In 2024, Medikit Co Ltd increased its cash reserves by 8.63%, or 1.52bn. The company earned 4.83bn from its operations for a Cash Flow Margin of 22.13%. In addition the company generated 3.23bn cash from investing, though they paid out 6.58bn more in financing than they received.
Cash flow per share | 288.48 |
---|---|
Price/Cash flow per share | 11.76 |
Book value per share | 3,015.35 |
---|---|
Tangible book value per share | 2,787.61 |
More ▼
Balance sheet in JPYView more
Current ratio | 5.45 |
---|---|
Quick ratio | 4.77 |
Total debt/total equity | 0.00 |
---|---|
Total debt/total capital | 0.00 |
More ▼
Growth rates in JPY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 14.29% and 10.12%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg) | 2.20% |
---|---|
Div growth rate (5 year) | 12.20% |
Payout ratio (TTM) | 44.00% |
EPS growth(5 years) | 4.34 |
---|---|
EPS (TTM) vs TTM 1 year ago | 10.90 |
More ▼